Artal Group S.A. - SQZ BIOTECHNOLOGIES CO ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of SQZ BIOTECHNOLOGIES CO
ValueSharesWeighting
Q3 2023$129
-70.3%
1,606,3090.0%0.01%
-53.8%
Q2 2023$434
-51.8%
1,606,3090.0%0.01%
-75.5%
Q1 2023$900
-24.3%
1,606,3090.0%0.05%
-19.7%
Q4 2022$1,189
-100.0%
1,606,3090.0%0.07%
-57.7%
Q3 2022$3,662,000
-28.3%
1,606,3090.0%0.16%
-42.9%
Q2 2022$5,108,000
-33.9%
1,606,3090.0%0.27%
-15.5%
Q1 2022$7,726,000
-46.1%
1,606,3090.0%0.32%
-17.0%
Q4 2021$14,344,000
-38.1%
1,606,3090.0%0.39%
-24.9%
Q3 2021$23,163,000
-0.2%
1,606,3090.0%0.52%
+10.0%
Q2 2021$23,211,000
+5.6%
1,606,3090.0%0.47%
+21.4%
Q1 2021$21,974,000
-52.8%
1,606,309
+0.0%
0.39%
-61.2%
Q4 2020$46,551,0001,606,3081.00%
Other shareholders
SQZ BIOTECHNOLOGIES CO shareholders Q4 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 1,330,889$984,8570.08%
Artal Group S.A. 1,606,309$1,1890.07%
Sandy Cove Advisors, LLC 51,707$38,2630.03%
MAVERICK CAPITAL LTD 1,068,155$790,4350.02%
AMERICAN INTERNATIONAL GROUP, INC. 2,517,173$1,862,7080.01%
Temasek Holdings (Private) Ltd 2,758,169$2,041,0450.01%
RBF Capital, LLC 127,930$94,0000.01%
ADVISORS MANAGEMENT GROUP INC /ADV 14,000$100.00%
Ergoteles LLC 64,215$47,5190.00%
Baldrige Asset Management LLC 5,000$40.00%
View complete list of SQZ BIOTECHNOLOGIES CO shareholders